The term “Long COVID” first emerged in the social media. Numerous affected individuals have reported in the social media about their various, long-lasting health limitations after SARS-CoV-2 infection. In the Berlin-Brandenburg metropolitan region,…
pharmtrace, a German, Berlin based provider of Independent expertise for nuclear medicine, diagnostics, and drug development clinical trials has established a representative office in Philadelphia. pharmtrace is currently enjoying increasing…
But that’s not all: the tool, which Altuna Akalin and his colleagues have now presented in “Science of the Total Environment”, can also find other pathogens.
Berlin, Germany and BELOIT, Wis., 11 October 2022 - Eckert & Ziegler Isotope Technologies Dresden (ITD), a specialist for radiopharmaceutical plant engineering and fully owned subsidiary of Eckert & Ziegler AG (ISIN DE0005659700, SDAX) and…
Professor Christof von Kalle, BIH Chair for Clinical Translational Sciences and Founding Director of the Clinical Study Center of the Berlin Institute of Health at Charité (BIH) and Charité – Universitätsmedizin Berlin, has been awarded the European…
The DIfE ─ German Diabetes Risk Score (DRS), developed by the German Institute of Human Nutrition Potsdam-Rehbruecke (DIfE), has thus far enabled the prediction of the individual risk of developing type 2 diabetes within the next five years.…
Financing led by Remiges Ventures, co-led by LifeCare Partners, with additional investments by Brandenburg Kapital, High-Tech Gründerfonds, Ventura Biomed Investors and undisclosed family offices.
Proceeds to be used to complete IND-enabling work…
NUVISAN’s integrated drug discovery expertise leveraged in a grant from the Bill & Melinda Gates Foundation
To prevent diseases from occurring in the first place, it is important to identify those individuals who are at particularly high risk as early as possible. Yet current screening methods are often costly and focus only on one disease at a time.…
BRCA1/2-mutated tumor cells often survive treatment, whether it’s chemo- or radiotherapy, because they can repair therapy-induced DNA damage. A team led by Claus Scheidereit of the Max Delbrück Center has now reported in The EMBO Journal how blocking…
